Advertisement

Topics

Serono France SA Company Profile

14:34 EDT 22nd October 2018 | BioPortfolio

Nil

Location

738, rue Yves-Kermen
Boulogne
CEDEX
F-92658
France

Contact

Phone: 33 (0)1 47 61 13 13
Fax: 33 (0)1 47 61 00 01
Email: contact.fr@serono.com


News Articles [190 Associated News Articles listed on BioPortfolio]

Merck Serono: Launching a New Corporate Venture Fund

In this episode of PharmaTelevision News Review, Paul Larsmon talks with Roel Bulthuis, Head at Merck Serono Ventures. Filmed at BIO-Europe 2009, they discuss: • Merck Serono's new corporate venture...

EMD Serono Taps Rehan Verjee as New President

EMD Serono is shaking up its leadership. The biopharmaceutical arm of Germany-based Merck KGaA named Rehan Verjee as the new president of EMD Serono and global head of innovative medicine franchises a...

Roel Bulthuis of Merck Serono Ventures- looking for new investment opportunities in oncology, neurodegeneration, inflammation, fertility and endocrinology

In this episode of PharmaTelevision News Review, Fintan Walton talks to Roel Bulthuis, Head of Merck Serono Ventures of Merck Serono SA

Merck Serono Secures Future Pipeline

In March 2009 Merck Serono announced that they had set up a strategic Venture Fund to invest in biotech companies with interesting programmes that are in line with Merck Serono’s strategic thinking....

Phillippe Lopes-Fernandes talks about Merck Serono’s strengths and successes in partnering

In this episode of PharmaTelevision News Review, Fintan Walton talks to Phillippe Lopes-Fernandes, Corporate VP, Head of Global Business Development at Merck Serono

EMD Serono: Philippe M Lopes-Fernandes. Closure of Geneva site creates opportunities for new business successes

In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Philippe M Lopes-Fernandes, Senior VP, Head of Global Licensing, Business ...

Accelerated Cure Project Collaborates with EMD Serono to Advance Patient-Focused Drug Development in Multiple Sclerosis

WALTHAM, Mass., Oct. 2, 2018 /PRNewswire/ — Accelerated Cure Project (ACP) for Multiple Sclerosis (MS) today announced it has entered into a ground-breaking collaboration with EMD Serono, the bi...

Rehan Verjee to Lead EMD Serono

Mr. Verjee will take accountability for the U.S. and Canada biopharmaceutical business

Drugs and Medications [367 Associated Drugs and Medications listed on BioPortfolio]

Cd hydra life pro-youth protective spf 15 [Parfums Christian Dior]

CD Hydra Life Pro-Youth Protective Creme SPF 15

Cd hydra life pro-youth protective fluid [Parfums Christian Dior]

CD Hydra Life Pro-Youth Protective Fluid

Rouge dior serum de rouge luminous color lip treatment 660 [Parfums Christian Dior]

Rouge Dior Serum de Rouge Luminous Color Lip Treatment 660

Rouge dior serum de rouge luminous color lip treatment 850 [Parfums Christian Dior]

Rouge Dior Serum de Rouge Luminous Color Lip Treatment 850

Rouge dior serum de rouge luminous color lip treatment 650 [Parfums Christian Dior]

Rouge Dior Serum de Rouge Luminous Color Lip Treatment 650

PubMed Articles [215 Associated PubMed Articles listed on BioPortfolio]

Emergence of bluetongue virus serotype 4 in mainland France in November 2017.

In November 2017, a 15-day-old calf located in France (Haute-Savoie department) was found positive for bluetongue virus (BTV) RNA by RT-PCR. Laboratory investigations allowed the isolation and identif...

Costs Associated with Hospitalisation in Hiv-Positive Patients in France.

To estimate the number of patients hospitalized for HIV-related reasons in France, to describe their characteristics and to estimate hospitalization-associated costs.

What is the evolution of stroke unit's accessibility in metropolitan France from 2009 to 2014? A trend analysis of over 600 000 patients using national hospital databases.

We aimed to study trends in stroke unit (SU) admission during a period of their deployment in France and to assess whether this led to better and more equitable access to this specialised care.

Effectiveness and cost of contraception in France (FACET study): a cohort study from the French National Healthcare Insurance Database.

To assess the effectiveness and costs associated with contraceptive methods based on real-world data in France.

Autochthonous Hepatitis E during Pregnancy, France.

Acute hepatitis E virus infections occurred during the third trimester in 2 pregnant women in France who sought treatment with nonspecific symptoms or asymptomatic elevation of liver enzymes. Infectio...

Clinical Trials [688 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.

Purpose of the study is the comparative evaluation of the clinical efficacy and of the general tolerability of two different subcutaneous FSH preparations (Fostimon® IBSA Vs Gonal-F® Ser...

Study of EMD531444 in Subjects With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Darmstadt, Germany, June 17 2010 - Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome ...

Follow-up Data of Patients Treated With XIGRIS® in France

The transparency commission wishes that the laboratory Lilly France sets up a follow-up study describing the conditions of use of Xigris® in France. The purpose of this study is to descr...

Survey on Epidemiology of Hypoparathyroidism in France

Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investig...

Iron Deficiency (ID) in Infants

ID in children is the most frequent micronutrient deficiency in industrialized countries, including France. ID induces neurological impairment reducing cognitive, motor, and behavioral cap...

Companies [345 Associated Companies listed on BioPortfolio]

Merck Serono

Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono ...

Serono France SA

Nil

Serono Inc.

Serono is a global biotechnology leader with over 4,750 employees and worldwide revenues of USD 2,586.4 million in the year 2005. We have eight biotechnology products on the market and currently more ...

Serono Laboratories Incorporated

We develop innovative products to fight debilitating diseases and improve the lives of our patients.We aspire to create an environment that enables our people to excel and innovate and to contribute t...

Serono Symposia International Foundation

More Information about "Serono France SA" on BioPortfolio

We have published hundreds of Serono France SA news stories on BioPortfolio along with dozens of Serono France SA Clinical Trials and PubMed Articles about Serono France SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Serono France SA Companies in our database. You can also find out about relevant Serono France SA Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record